))
Why Industry-Wide Standards Matter In Fulfilling the Intent of DSCSA
Manage episode 388829646 series 3472284
内容由Tory Cenaj提供。所有播客内容（包括剧集、图形和播客描述）均由 Tory Cenaj 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。
Why Industry-Wide Standards Matter In Fulfilling the Intent of DSCSA
- Christiane Wirrig, PhD | Customer Success Manager, Spherity
- David Kessler | Co-owner and President, Legisym
Discussion on the importance of standardization in order to digitalize the U.S. pharmaceutical supply chain as motivated by the Drug Supply Chain Security Act (DSCSA).
Key topics
- What is DSCSA?
- What does FDA’s Stabilization Period mean?
- Why do technology standards matter and how are they being implemented, i.e. interoperability through standards?
- Focus on standardization, due diligence in the context of DSCSA-regulated digitally managed pharma supply chain
- 2023 readiness in relation to stabilization period until 2024
- Inspections will keep happening
- ATP is mandatory, authentication & authorization
- Data security
238集单集
分享
